Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry.

Liu Y, Sogawa K, Sunaga M, Umemura H, Satoh M, Kazami T, Yoshikawa M, Tomonaga T, Yokosuka O, Nomura F.

Am J Clin Pathol. 2014 Jan;141(1):52-61. doi: 10.1309/AJCPBLFBNAP6N2UN.

PMID:
24343737
[PubMed - indexed for MEDLINE]
2.

Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Liu T, Xue R, Huang X, Zhang D, Dong L, Wu H, Shen X.

Acta Biochim Biophys Sin (Shanghai). 2011 Jul;43(7):542-50. doi: 10.1093/abbs/gmr044. Epub 2011 Jun 9.

PMID:
21659380
[PubMed - indexed for MEDLINE]
3.

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.

Paradis V, Degos F, Dargère D, Pham N, Belghiti J, Degott C, Janeau JL, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P.

Hepatology. 2005 Jan;41(1):40-7.

PMID:
15690480
[PubMed - indexed for MEDLINE]
4.

Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.

Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.

J Gastroenterol Hepatol. 2009 Jan;24(1):55-62. doi: 10.1111/j.1440-1746.2008.05580.x. Epub 2008 Sep 24.

PMID:
18823443
[PubMed - indexed for MEDLINE]
5.

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.

Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.

Clin Cancer Res. 2008 Jan 15;14(2):470-7. doi: 10.1158/1078-0432.CCR-07-0586.

PMID:
18223221
[PubMed - indexed for MEDLINE]
Free Article
6.

Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.

Mustafa MG, Petersen JR, Ju H, Cicalese L, Snyder N, Haidacher SJ, Denner L, Elferink C.

Mol Cell Proteomics. 2013 Dec;12(12):3640-52. doi: 10.1074/mcp.M113.031252. Epub 2013 Sep 5.

PMID:
24008390
[PubMed - indexed for MEDLINE]
7.

Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.

Liao J, Zhang R, Qian H, Cao L, Zhang Y, Xu W, Li J, Wu M, Yin Z.

Biochem Biophys Res Commun. 2012 Apr 6;420(2):308-14. doi: 10.1016/j.bbrc.2012.02.155. Epub 2012 Mar 7.

PMID:
22425980
[PubMed - indexed for MEDLINE]
8.

Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.

Wu FX, Wang Q, Zhang ZM, Huang S, Yuan WP, Liu JY, Ban KC, Zhao YN.

Cancer Lett. 2009 Jul 8;279(2):163-70. doi: 10.1016/j.canlet.2009.01.034. Epub 2009 Mar 5.

PMID:
19268439
[PubMed - indexed for MEDLINE]
9.

Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.

Ressom HW, Varghese RS, Goldman L, An Y, Loffredo CA, Abdel-Hamid M, Kyselova Z, Mechref Y, Novotny M, Drake SK, Goldman R.

J Proteome Res. 2008 Feb;7(2):603-10. doi: 10.1021/pr0705237. Epub 2008 Jan 12.

PMID:
18189345
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.

Göbel T, Vorderwülbecke S, Hauck K, Fey H, Häussinger D, Erhardt A.

World J Gastroenterol. 2006 Dec 21;12(47):7604-12.

PMID:
17171788
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.

Cui J, Kang X, Dai Z, Huang C, Zhou H, Guo K, Li Y, Zhang Y, Sun R, Chen J, Li Y, Tang Z, Uemura T, Liu Y.

J Cancer Res Clin Oncol. 2007 Nov;133(11):825-34. Epub 2007 May 22.

PMID:
17516088
[PubMed - indexed for MEDLINE]
12.

Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.

Wang JX, Zhang B, Yu JK, Liu J, Yang MQ, Zheng S.

Chin Med J (Engl). 2005 Aug 5;118(15):1278-84.

PMID:
16117882
[PubMed - indexed for MEDLINE]
Free Article
13.

MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.

Liu C, Shen J, Pan C, Yang L, Mou S, Wang H, Liang Y.

Am J Clin Pathol. 2010 Aug;134(2):235-41. doi: 10.1309/AJCPA6C6NOGFLYIR.

PMID:
20660326
[PubMed - indexed for MEDLINE]
Free Article
14.

Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry.

Varghese RS, Goldman L, An Y, Loffredo CA, Abdel-Hamid M, Kyselova Z, Mechref Y, Novotny M, Drake SK, Goldman R, Ressom HW.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3791-4. doi: 10.1109/IEMBS.2008.4650034.

PMID:
19163537
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.

Saito Y, Oba N, Nishinakagawa S, Mizuguchi Y, Kojima T, Nomura K, Nakatsura T.

Oncol Rep. 2010 May;23(5):1325-30.

PMID:
20372847
[PubMed - indexed for MEDLINE]
16.

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J, Leng X, Poon RT, Luk JM.

Ann Surg Oncol. 2010 Sep;17(9):2518-25. doi: 10.1245/s10434-010-1038-8. Epub 2010 Mar 31.

PMID:
20354800
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis.

Cui JF, Liu YK, Zhou HJ, Kang XN, Huang C, He YF, Tang ZY, Uemura T.

World J Gastroenterol. 2008 Feb 28;14(8):1257-62.

PMID:
18300354
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.

Geng X, Wang F, Li YG, Zhu GP, Zhang WM.

J Exp Clin Cancer Res. 2007 Dec;26(4):505-8.

PMID:
18365545
[PubMed - indexed for MEDLINE]
19.

Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.

Orvisky E, Drake SK, Martin BM, Abdel-Hamid M, Ressom HW, Varghese RS, An Y, Saha D, Hortin GL, Loffredo CA, Goldman R.

Proteomics. 2006 May;6(9):2895-902.

PMID:
16586431
[PubMed - indexed for MEDLINE]
20.

Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers.

Ressom HW, Varghese RS, Goldman L, Loffredo CA, Abdel-Hamid M, Kyselova Z, Mechref Y, Novotny M, Goldman R.

Pac Symp Biocomput. 2008:216-27.

PMID:
18229688
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk